Literature DB >> 26050587

Advances in Magnetic Resonance and Positron Emission Tomography Imaging: Assessing Response in the Treatment of Low-Grade Glioma.

Michelle M Kim1, Theodore S Lawrence2, Yue Cao3.   

Abstract

Following combined-modality therapy for the treatment of low-grade gliomas, the assessment of treatment response and the evaluation of disease progression are uniformly challenging. In this article, we review existing response criteria, and discuss the limitations of conventional magnetic resonance imaging to distinguish between progression and treatment effect. We review the data on advanced imaging techniques including positron emission tomography and functional magnetic resonance imaging, which may enhance the interpretation of posttreatment changes, and enable the earlier assessment of the efficacy and toxicity of therapy in these patients with prolonged survival. Published by Elsevier Inc.

Entities:  

Mesh：

Year:  2015        PMID： 26050587      PMCID： PMC4460607          DOI： 10.1016/j.semradonc.2015.02.003

Source DB:  PubMed          Journal:  Semin Radiat Oncol        ISSN： 1053-4296            Impact factor:   5.934


  52 in total

1.  Diffusion tensor imaging of normal-appearing white matter as biomarker for radiation-induced late delayed cognitive decline.

Authors:  Christopher H Chapman; Vijaya Nagesh; Pia C Sundgren; Henry Buchtel; Thomas L Chenevert; Larry Junck; Theodore S Lawrence; Christina I Tsien; Yue Cao
Journal:  Int J Radiat Oncol Biol Phys       Date:  2011-05-11       Impact factor: 7.038

2.  FLT-PET in previously untreated patients with low-grade glioma can predict their overall survival.

Authors:  Otakar Belohlavek; Pavel Fencl; Martin Majovsky; Monika Jaruskova; Vladimir Benes
Journal:  Nucl Med Rev Cent East Eur       Date:  2014

3.  Functional diffusion map: a noninvasive MRI biomarker for early stratification of clinical brain tumor response.

Authors:  Bradford A Moffat; Thomas L Chenevert; Theodore S Lawrence; Charles R Meyer; Timothy D Johnson; Qian Dong; Christina Tsien; Suresh Mukherji; Douglas J Quint; Stephen S Gebarski; Patricia L Robertson; Larry R Junck; Alnawaz Rehemtulla; Brian D Ross
Journal:  Proc Natl Acad Sci U S A       Date:  2005-04-01       Impact factor: 11.205

4.  Imaging proliferation in brain tumors with 18F-FLT PET: comparison with 18F-FDG.

Authors:  Wei Chen; Timothy Cloughesy; Nirav Kamdar; Nagichettiar Satyamurthy; Marvin Bergsneider; Linda Liau; Paul Mischel; Johannes Czernin; Michael E Phelps; Daniel H S Silverman
Journal:  J Nucl Med       Date:  2005-06       Impact factor: 10.057

5.  Long-term efficacy of early versus delayed radiotherapy for low-grade astrocytoma and oligodendroglioma in adults: the EORTC 22845 randomised trial.

Authors:  M J van den Bent; D Afra; O de Witte; M Ben Hassel; S Schraub; K Hoang-Xuan; P-O Malmström; L Collette; M Piérart; R Mirimanoff; A B M F Karim
Journal:  Lancet       Date:  2005 Sep 17-23       Impact factor: 79.321

6.  Utility of relative cerebral blood volume mapping derived from perfusion magnetic resonance imaging in the routine follow up of brain tumors.

Authors:  T Siegal; R Rubinstein; T Tzuk-Shina; J M Gomori
Journal:  J Neurosurg       Date:  1997-01       Impact factor: 5.115

7.  Comparison of 18F-fluorodeoxyglucose and 18F-fluorothymidine PET in differentiating radiation necrosis from recurrent glioma.

Authors:  Michael S Enslow; Lauren V Zollinger; Kathryn A Morton; Regan I Butterfield; Dan J Kadrmas; Paul E Christian; Kenneth M Boucher; Marta E Heilbrun; Randy L Jensen; John M Hoffman
Journal:  Clin Nucl Med       Date:  2012-09       Impact factor: 7.794

8.  Correlation of MR imaging-determined cerebral blood volume maps with histologic and angiographic determination of vascularity of gliomas.

Authors:  T Sugahara; Y Korogi; M Kochi; I Ikushima; T Hirai; T Okuda; Y Shigematsu; L Liang; Y Ge; Y Ushio; M Takahashi
Journal:  AJR Am J Roentgenol       Date:  1998-12       Impact factor: 3.959

Review 9.  Physiologic and metabolic magnetic resonance imaging in gliomas.

Authors:  Yue Cao; Pia C Sundgren; Christina I Tsien; Thomas T Chenevert; Larry Junck
Journal:  J Clin Oncol       Date:  2006-03-10       Impact factor: 44.544

10.  2-hydroxyglutarate detection by magnetic resonance spectroscopy in IDH-mutated patients with gliomas.

Authors:  Changho Choi; Sandeep K Ganji; Ralph J DeBerardinis; Kimmo J Hatanpaa; Dinesh Rakheja; Zoltan Kovacs; Xiao-Li Yang; Tomoyuki Mashimo; Jack M Raisanen; Isaac Marin-Valencia; Juan M Pascual; Christopher J Madden; Bruce E Mickey; Craig R Malloy; Robert M Bachoo; Elizabeth A Maher
Journal:  Nat Med       Date:  2012-01-26       Impact factor: 53.440
View more
  1 in total

Review 1.  Nanoparticle Drug Delivery System for Glioma and Its Efficacy Improvement Strategies: A Comprehensive Review.

Authors:  Jie Li; Jiaqian Zhao; Tiantian Tan; Mengmeng Liu; Zhaowu Zeng; Yiying Zeng; Lele Zhang; Chaomei Fu; Dajing Chen; Tian Xie
Journal:  Int J Nanomedicine       Date:  2020-04-17
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.